Beneficial Read-Through of aUSH1CNonsense Mutation by Designed Aminoglycoside NB30 in the Retina-Reference-Cited by-同舟云学术

Beneficial Read-Through of aUSH1CNonsense Mutation by Designed Aminoglycoside NB30 in the Retina

Published:2010-12-01 Issue:12 Volume:51 Page:6671
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Goldmann Tobias¹,Rebibo-Sabbah Annie²,Overlack Nora¹,Nudelman Igor³,Belakhov Valery³,Baasov Timor³,Ben-Yosef Tamar²,Wolfrum Uwe¹,Nagel-Wolfrum Kerstin¹

Affiliation:

1. From the Institute of Zoology, Department of Cell and Matrix Biology, Johannes Gutenberg-University of Mainz, Mainz, Germany; and

2. the Department of Genetics and The Rappaport Family Institute for Research in the Medical Sciences, Rappaport Faculty of Medicine, and

3. the Edith and Joseph Fischer Enzyme Inhibitors Laboratory, Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, Israel.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons;Pharmaceuticals;2024-02-28

2. Advances towards personalized therapies for Stargardt disease;Expert Review of Ophthalmology;2023-09-03

3. Recoding of Nonsense Mutation as a Pharmacological Strategy;Biomedicines;2023-02-22

4. The Usher syndrome 1C protein harmonin regulates canonical Wnt signaling;Frontiers in Cell and Developmental Biology;2023-02-08

5. Factors Affecting Readthrough of Natural Versus Premature Termination Codons;Retinal Degenerative Diseases XIX;2023